Substance Use Disorders in Schizophrenia—Clinical Implications of Comorbidity

Nearly half of the people suffering from schizophrenia also present with a lifetime history of substance use disorders (SUD), a rate that is much higher than the one seen among unaffected individuals. This phenomenon suggests that the factors influencing SUD risk in schizophrenia may be more numerou...

Descripción completa

Detalles Bibliográficos
Autor principal: Volkow, Nora D.
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2009
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2669586/
https://www.ncbi.nlm.nih.gov/pubmed/19325163
http://dx.doi.org/10.1093/schbul/sbp016
_version_ 1782166268519907328
author Volkow, Nora D.
author_facet Volkow, Nora D.
author_sort Volkow, Nora D.
collection PubMed
description Nearly half of the people suffering from schizophrenia also present with a lifetime history of substance use disorders (SUD), a rate that is much higher than the one seen among unaffected individuals. This phenomenon suggests that the factors influencing SUD risk in schizophrenia may be more numerous and/or complex than those modulating SUD risk in the general population. It is critically important to address this comorbidity because SUD in schizophrenic patients is associated with poorer clinical outcomes and contributes significantly to their morbidity and mortality.
format Text
id pubmed-2669586
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-26695862009-05-15 Substance Use Disorders in Schizophrenia—Clinical Implications of Comorbidity Volkow, Nora D. Schizophr Bull Editorial Nearly half of the people suffering from schizophrenia also present with a lifetime history of substance use disorders (SUD), a rate that is much higher than the one seen among unaffected individuals. This phenomenon suggests that the factors influencing SUD risk in schizophrenia may be more numerous and/or complex than those modulating SUD risk in the general population. It is critically important to address this comorbidity because SUD in schizophrenic patients is associated with poorer clinical outcomes and contributes significantly to their morbidity and mortality. Oxford University Press 2009-05 2009-03-26 /pmc/articles/PMC2669586/ /pubmed/19325163 http://dx.doi.org/10.1093/schbul/sbp016 Text en © 2009 The Authors This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Editorial
Volkow, Nora D.
Substance Use Disorders in Schizophrenia—Clinical Implications of Comorbidity
title Substance Use Disorders in Schizophrenia—Clinical Implications of Comorbidity
title_full Substance Use Disorders in Schizophrenia—Clinical Implications of Comorbidity
title_fullStr Substance Use Disorders in Schizophrenia—Clinical Implications of Comorbidity
title_full_unstemmed Substance Use Disorders in Schizophrenia—Clinical Implications of Comorbidity
title_short Substance Use Disorders in Schizophrenia—Clinical Implications of Comorbidity
title_sort substance use disorders in schizophrenia—clinical implications of comorbidity
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2669586/
https://www.ncbi.nlm.nih.gov/pubmed/19325163
http://dx.doi.org/10.1093/schbul/sbp016
work_keys_str_mv AT volkownorad substanceusedisordersinschizophreniaclinicalimplicationsofcomorbidity

Ejemplares similares